Jakavi.com
- Title
- JAKAVI (ruxolitinib) a JAK1 & JAK2 Inhibitor for MF & PV Treatment | JAKAVI
- Meta Description
- JAKAVI is indicated for the treatment of adult patients with Myelofibrosis and adult patients with Polycythaemia Vera who are resistant to or intolerant of hydroxyurea
- Meta Keywords
- JAKAVI, ruxolitinib, polycythaemia vera, polycythemia vera, PV treatment, JAK1/JAK2 inhibitor, JAK inhibitor